| 0 |
ANTI FACTOR V ANTIBODY |
22 |
0.7857 |
| 1 |
MENINGITIS CANDIDA |
23 |
0.3286 |
| 2 |
PROTOTHECOSIS |
27 |
0.2872 |
| 3 |
GEOTRICHUM INFECTION |
60 |
0.2844 |
| 4 |
INTRACRANIAL INFECTION |
25 |
0.2000 |
| 5 |
FOETAL ANAEMIA |
24 |
0.1832 |
| 6 |
TRICHOSPORON INFECTION |
73 |
0.1802 |
| 7 |
RHINOCEREBRAL MUCORMYCOSIS |
52 |
0.1499 |
| 8 |
HERPES SIMPLEX OESOPHAGITIS |
27 |
0.1452 |
| 9 |
PERINEPHRIC ABSCESS |
20 |
0.1316 |
| 10 |
DISSEMINATED MUCORMYCOSIS |
51 |
0.1294 |
| 11 |
EMPHYSEMATOUS PYELONEPHRITIS |
23 |
0.1257 |
| 12 |
URINARY TRACT CANDIDIASIS |
24 |
0.1257 |
| 13 |
DYSBIOSIS |
102 |
0.1242 |
| 14 |
ACINETOBACTER INFECTION |
135 |
0.1233 |
| 15 |
AEROMONAS INFECTION |
23 |
0.1217 |
| 16 |
SYSTEMIC CANDIDA |
284 |
0.1130 |
| 17 |
FACTOR V INHIBITION |
20 |
0.1031 |
| 18 |
STENOTROPHOMONAS INFECTION |
129 |
0.0951 |
| 19 |
CONGENITAL MULTIPLEX ARTHROGRYPOSIS |
19 |
0.0931 |
| 20 |
SPINAL MUSCULAR ATROPHY |
25 |
0.0926 |
| 21 |
FUNGAEMIA |
144 |
0.0914 |
| 22 |
CNS VENTRICULITIS |
29 |
0.0890 |
| 23 |
CONDUCTIVE DEAFNESS |
28 |
0.0872 |
| 24 |
FUSARIUM INFECTION |
60 |
0.0857 |
| 25 |
SCEDOSPORIUM INFECTION |
58 |
0.0822 |
| 26 |
CEREBRAL NOCARDIOSIS |
19 |
0.0815 |
| 27 |
FUNGAL ENDOCARDITIS |
23 |
0.0764 |
| 28 |
POSITIVE AIRWAY PRESSURE THERAPY |
21 |
0.0719 |
| 29 |
CANDIDA SEPSIS |
64 |
0.0713 |
| 30 |
SPLENIC ABSCESS |
29 |
0.0713 |
| 31 |
ENTEROCOCCAL INFECTION |
337 |
0.0697 |
| 32 |
SYSTEMIC MYCOSIS |
81 |
0.0693 |
| 33 |
ENTEROCOCCAL SEPSIS |
56 |
0.0691 |
| 34 |
CLOSTRIDIUM TEST POSITIVE |
149 |
0.0675 |
| 35 |
PATHOGEN RESISTANCE |
602 |
0.0660 |
| 36 |
MYCOBACTERIUM ABSCESSUS INFECTION |
47 |
0.0657 |
| 37 |
HYPHAEMA |
34 |
0.0651 |
| 38 |
FUNGAL SEPSIS |
54 |
0.0650 |
| 39 |
PROCALCITONIN INCREASED |
76 |
0.0647 |
| 40 |
INFECTIVE ANEURYSM |
32 |
0.0646 |
| 41 |
VANCOMYCIN INFUSION REACTION |
24 |
0.0637 |
| 42 |
DISSEMINATED ASPERGILLOSIS |
30 |
0.0636 |
| 43 |
ABDOMINAL COMPARTMENT SYNDROME |
40 |
0.0628 |
| 44 |
THROMBOCYTOPENIA NEONATAL |
26 |
0.0618 |
| 45 |
PSEUDOMEMBRANOUS COLITIS |
138 |
0.0617 |
| 46 |
BRAIN ABSCESS |
149 |
0.0588 |
| 47 |
ENTEROCOCCUS TEST POSITIVE |
38 |
0.0586 |
| 48 |
RESPIRATORY TRACT INFECTION BACTERIAL |
29 |
0.0582 |
| 49 |
PYROGLUTAMIC ACIDOSIS |
23 |
0.0579 |
| 50 |
RESPIRATORY GAS EXCHANGE DISORDER |
21 |
0.0566 |
| 51 |
UREAPLASMA INFECTION |
23 |
0.0564 |
| 52 |
MUCORMYCOSIS |
146 |
0.0561 |
| 53 |
BRONCHOPLEURAL FISTULA |
21 |
0.0559 |
| 54 |
PULMONARY NECROSIS |
19 |
0.0557 |
| 55 |
HEPATIC INFARCTION |
21 |
0.0557 |
| 56 |
CARDIAC VALVE VEGETATION |
27 |
0.0556 |
| 57 |
LINEAR IGA DISEASE |
92 |
0.0553 |
| 58 |
PNEUMOCOCCAL SEPSIS |
35 |
0.0533 |
| 59 |
KLEBSIELLA INFECTION |
269 |
0.0531 |
| 60 |
CANDIDA TEST POSITIVE |
22 |
0.0526 |
| 61 |
MEDIASTINITIS |
30 |
0.0517 |
| 62 |
ANAL INFLAMMATION |
33 |
0.0516 |
| 63 |
TUMOUR ASSOCIATED FEVER |
21 |
0.0513 |
| 64 |
KLEBSIELLA BACTERAEMIA |
48 |
0.0505 |
| 65 |
BRONCHOPULMONARY ASPERGILLOSIS |
385 |
0.0496 |
| 66 |
ANTIBIOTIC LEVEL ABOVE THERAPEUTIC |
20 |
0.0493 |
| 67 |
PULMONARY MUCORMYCOSIS |
26 |
0.0492 |
| 68 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
1379 |
0.0486 |
| 69 |
ENTEROCOCCAL BACTERAEMIA |
49 |
0.0462 |
| 70 |
NOCARDIOSIS |
116 |
0.0453 |
| 71 |
LOWER RESPIRATORY TRACT INFECTION BACTERIAL |
23 |
0.0450 |
| 72 |
HYPERFERRITINAEMIA |
19 |
0.0441 |
| 73 |
CEREBRAL ASPERGILLOSIS |
27 |
0.0439 |
| 74 |
MULTIPLE-DRUG RESISTANCE |
136 |
0.0438 |
| 75 |
PULMONARY NOCARDIOSIS |
36 |
0.0437 |
| 76 |
PNEUMONIA NECROTISING |
28 |
0.0433 |
| 77 |
SARS-COV-2 TEST NEGATIVE |
29 |
0.0430 |
| 78 |
SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA |
35 |
0.0426 |
| 79 |
ASPERGILLUS INFECTION |
278 |
0.0423 |
| 80 |
SEPSIS SYNDROME |
21 |
0.0418 |
| 81 |
URINARY TRACT INFECTION FUNGAL |
23 |
0.0401 |
| 82 |
PNEUMONIA PSEUDOMONAL |
61 |
0.0397 |
| 83 |
PSEUDOMONAS INFECTION |
336 |
0.0391 |
| 84 |
NEUTROPENIC COLITIS |
81 |
0.0391 |
| 85 |
MOTOR NEURONE DISEASE |
19 |
0.0390 |
| 86 |
EOSINOPHILIC PNEUMONIA ACUTE |
33 |
0.0381 |
| 87 |
TRACHEOBRONCHITIS |
29 |
0.0377 |
| 88 |
PSEUDOMONAL BACTERAEMIA |
32 |
0.0375 |
| 89 |
DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY |
35 |
0.0370 |
| 90 |
DELAYED GRAFT FUNCTION |
26 |
0.0366 |
| 91 |
STRONGYLOIDIASIS |
59 |
0.0365 |
| 92 |
HAEMOPERITONEUM |
29 |
0.0362 |
| 93 |
URINARY TRACT INFECTION ENTEROCOCCAL |
33 |
0.0353 |
| 94 |
JARISCH-HERXHEIMER REACTION |
25 |
0.0351 |
| 95 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
263 |
0.0350 |
| 96 |
BACILLUS INFECTION |
22 |
0.0348 |
| 97 |
SEPTIC SHOCK |
1508 |
0.0346 |
| 98 |
PNEUMONIA FUNGAL |
136 |
0.0344 |
| 99 |
HYPOFIBRINOGENAEMIA |
34 |
0.0343 |
| 100 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
876 |
0.0340 |
| 101 |
OTOTOXICITY |
62 |
0.0335 |
| 102 |
DRUG RESISTANCE |
861 |
0.0335 |
| 103 |
DISSEMINATED CRYPTOCOCCOSIS |
25 |
0.0330 |
| 104 |
PSEUDOMONAS TEST POSITIVE |
27 |
0.0330 |
| 105 |
LIVER ABSCESS |
107 |
0.0330 |
| 106 |
RASH MORBILLIFORM |
91 |
0.0328 |
| 107 |
ENTEROBACTER INFECTION |
55 |
0.0327 |
| 108 |
ANTICONVULSANT DRUG LEVEL DECREASED |
46 |
0.0326 |
| 109 |
PSEUDOMONAL SEPSIS |
57 |
0.0325 |
| 110 |
VIRAL HAEMORRHAGIC CYSTITIS |
23 |
0.0323 |
| 111 |
DEVICE RELATED SEPSIS |
65 |
0.0323 |
| 112 |
CYTOKINE STORM |
22 |
0.0321 |
| 113 |
GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT |
68 |
0.0319 |
| 114 |
ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC |
24 |
0.0319 |
| 115 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
120 |
0.0314 |
| 116 |
PNEUMONIA KLEBSIELLA |
57 |
0.0310 |
| 117 |
TOXIC EPIDERMAL NECROLYSIS |
470 |
0.0309 |
| 118 |
BLOOD FIBRINOGEN DECREASED |
35 |
0.0306 |
| 119 |
CLOSTRIDIUM DIFFICILE COLITIS |
325 |
0.0306 |
| 120 |
HISTIOCYTOSIS HAEMATOPHAGIC |
89 |
0.0299 |
| 121 |
HYPERCHLORAEMIA |
19 |
0.0297 |
| 122 |
METHAEMOGLOBINAEMIA |
68 |
0.0293 |
| 123 |
MENINGITIS BACTERIAL |
42 |
0.0293 |
| 124 |
INFECTION IN AN IMMUNOCOMPROMISED HOST |
21 |
0.0292 |
| 125 |
MICROANGIOPATHIC HAEMOLYTIC ANAEMIA |
23 |
0.0292 |
| 126 |
HYPERLACTACIDAEMIA |
78 |
0.0291 |
| 127 |
DIFFERENTIATION SYNDROME |
21 |
0.0286 |
| 128 |
BACTERIAL SEPSIS |
92 |
0.0282 |
| 129 |
GRAFT VERSUS HOST DISEASE IN LIVER |
20 |
0.0279 |
| 130 |
NEPHROGENIC DIABETES INSIPIDUS |
32 |
0.0277 |
| 131 |
PULMONARY CAVITATION |
24 |
0.0276 |
| 132 |
CANDIDA INFECTION |
465 |
0.0275 |
| 133 |
LUNG CONSOLIDATION |
77 |
0.0275 |
| 134 |
CYTOMEGALOVIRUS TEST POSITIVE |
49 |
0.0275 |
| 135 |
ACUTE MYELOID LEUKAEMIA RECURRENT |
59 |
0.0275 |
| 136 |
MEGACOLON |
42 |
0.0267 |
| 137 |
KLEBSIELLA SEPSIS |
30 |
0.0266 |
| 138 |
SEPTIC EMBOLUS |
22 |
0.0264 |
| 139 |
APLASTIC ANAEMIA |
137 |
0.0262 |
| 140 |
WHITE MATTER LESION |
33 |
0.0261 |
| 141 |
EOSINOPHILIA |
450 |
0.0257 |
| 142 |
INFECTIOUS PLEURAL EFFUSION |
38 |
0.0250 |
| 143 |
BRONCHOPULMONARY DYSPLASIA |
20 |
0.0248 |
| 144 |
FEBRILE INFECTION |
29 |
0.0246 |
| 145 |
RENAL ABSCESS |
20 |
0.0244 |
| 146 |
EOSINOPHILIC PNEUMONIA |
77 |
0.0244 |
| 147 |
DISSEMINATED INTRAVASCULAR COAGULATION |
344 |
0.0244 |
| 148 |
ESCHERICHIA BACTERAEMIA |
57 |
0.0242 |
| 149 |
HAEMATOLOGICAL INFECTION |
59 |
0.0241 |
| 150 |
ISCHAEMIC CEREBRAL INFARCTION |
28 |
0.0241 |
| 151 |
BACTERAEMIA |
286 |
0.0241 |
| 152 |
NOSOCOMIAL INFECTION |
53 |
0.0240 |
| 153 |
MIXED LIVER INJURY |
71 |
0.0236 |
| 154 |
SPUTUM INCREASED |
51 |
0.0236 |
| 155 |
THERAPEUTIC PRODUCT CROSS-REACTIVITY |
21 |
0.0235 |
| 156 |
LISTERIOSIS |
26 |
0.0235 |
| 157 |
TYPE IV HYPERSENSITIVITY REACTION |
64 |
0.0233 |
| 158 |
VANISHING BILE DUCT SYNDROME |
26 |
0.0233 |
| 159 |
HYPOPROTEINAEMIA |
44 |
0.0232 |
| 160 |
STAPHYLOCOCCAL BACTERAEMIA |
99 |
0.0228 |
| 161 |
DERMATITIS EXFOLIATIVE GENERALISED |
79 |
0.0227 |
| 162 |
APLASIA |
44 |
0.0224 |
| 163 |
SUBCUTANEOUS EMPHYSEMA |
22 |
0.0224 |
| 164 |
INFLAMMATORY MARKER INCREASED |
111 |
0.0224 |
| 165 |
IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME |
132 |
0.0223 |
| 166 |
GRAFT VERSUS HOST DISEASE IN SKIN |
49 |
0.0222 |
| 167 |
NECROTISING COLITIS |
28 |
0.0221 |
| 168 |
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE |
31 |
0.0219 |
| 169 |
HYPOPERFUSION |
23 |
0.0219 |
| 170 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
387 |
0.0219 |
| 171 |
METABOLIC ALKALOSIS |
35 |
0.0218 |
| 172 |
PNEUMOCYSTIS JIROVECII INFECTION |
26 |
0.0218 |
| 173 |
HYPERLEUKOCYTOSIS |
19 |
0.0214 |
| 174 |
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS |
162 |
0.0208 |
| 175 |
HYPOGONADISM |
21 |
0.0208 |
| 176 |
BRAIN HERNIATION |
62 |
0.0207 |
| 177 |
CROSS SENSITIVITY REACTION |
20 |
0.0205 |
| 178 |
ENCEPHALITIS VIRAL |
25 |
0.0205 |
| 179 |
TOXIC ENCEPHALOPATHY |
104 |
0.0205 |
| 180 |
HAEMODYNAMIC INSTABILITY |
156 |
0.0205 |
| 181 |
PNEUMOMEDIASTINUM |
37 |
0.0205 |
| 182 |
ADENOVIRUS INFECTION |
59 |
0.0203 |
| 183 |
HEPATOSPLENOMEGALY |
52 |
0.0202 |
| 184 |
HEPATITIS CHOLESTATIC |
122 |
0.0202 |
| 185 |
IMMUNOSUPPRESSANT DRUG LEVEL DECREASED |
24 |
0.0200 |
| 186 |
CEREBRAL PALSY |
19 |
0.0200 |
| 187 |
PULMONARY SEPSIS |
29 |
0.0199 |
| 188 |
ENDOCARDITIS |
102 |
0.0199 |
| 189 |
PNEUMONIA BACTERIAL |
182 |
0.0198 |
| 190 |
OLIGURIA |
122 |
0.0196 |
| 191 |
JOINT CONTRACTURE |
21 |
0.0196 |
| 192 |
HEPATITIS FULMINANT |
58 |
0.0195 |
| 193 |
CHOLESTATIC LIVER INJURY |
43 |
0.0193 |
| 194 |
HYPOALBUMINAEMIA |
150 |
0.0193 |
| 195 |
INFECTION REACTIVATION |
22 |
0.0192 |
| 196 |
HYPERNATRAEMIA |
95 |
0.0190 |
| 197 |
FOLATE DEFICIENCY |
22 |
0.0190 |
| 198 |
CARDIOVASCULAR INSUFFICIENCY |
31 |
0.0190 |
| 199 |
VENOOCCLUSIVE LIVER DISEASE |
94 |
0.0190 |
| 200 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
50 |
0.0188 |
| 201 |
NECROTISING FASCIITIS |
65 |
0.0184 |
| 202 |
HAEMORRHAGIC DISORDER |
20 |
0.0184 |
| 203 |
IMMUNOSUPPRESSANT DRUG LEVEL INCREASED |
60 |
0.0181 |
| 204 |
RASH MACULO-PAPULAR |
404 |
0.0181 |
| 205 |
LUNG ABSCESS |
38 |
0.0181 |
| 206 |
COAGULATION TIME PROLONGED |
28 |
0.0181 |
| 207 |
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN |
50 |
0.0181 |
| 208 |
CRYPTOCOCCOSIS |
29 |
0.0178 |
| 209 |
NEUTROPENIC SEPSIS |
127 |
0.0178 |
| 210 |
CYTOMEGALOVIRUS VIRAEMIA |
79 |
0.0177 |
| 211 |
ASPERGILLOSIS |
23 |
0.0176 |
| 212 |
EXCESSIVE EYE BLINKING |
26 |
0.0176 |
| 213 |
FEBRILE NEUTROPENIA |
1167 |
0.0176 |
| 214 |
ISCHAEMIC HEPATITIS |
24 |
0.0175 |
| 215 |
OBLITERATIVE BRONCHIOLITIS |
23 |
0.0175 |
| 216 |
DIFFUSE ALVEOLAR DAMAGE |
20 |
0.0174 |
| 217 |
BRONCHIAL DISORDER |
27 |
0.0174 |
| 218 |
MECHANICAL VENTILATION |
33 |
0.0174 |
| 219 |
PULMONARY HAEMORRHAGE |
135 |
0.0172 |
| 220 |
AGRANULOCYTOSIS |
320 |
0.0172 |
| 221 |
RETROPERITONEAL HAEMATOMA |
38 |
0.0172 |
| 222 |
H1N1 INFLUENZA |
24 |
0.0171 |
| 223 |
STAPHYLOCOCCUS TEST POSITIVE |
36 |
0.0171 |
| 224 |
PNEUMONIA CYTOMEGALOVIRAL |
33 |
0.0170 |
| 225 |
STAPHYLOCOCCAL SEPSIS |
83 |
0.0168 |
| 226 |
BICYTOPENIA |
32 |
0.0163 |
| 227 |
RESPIRATORY FAILURE |
1185 |
0.0162 |
| 228 |
ESCHERICHIA INFECTION |
133 |
0.0162 |
| 229 |
ENTEROCOLITIS |
93 |
0.0161 |
| 230 |
VASCULAR PSEUDOANEURYSM |
28 |
0.0161 |
| 231 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
71 |
0.0161 |
| 232 |
SHOCK HAEMORRHAGIC |
130 |
0.0160 |
| 233 |
HYPERTRANSAMINASAEMIA |
111 |
0.0159 |
| 234 |
INTERVERTEBRAL DISCITIS |
30 |
0.0159 |
| 235 |
TOXIC SKIN ERUPTION |
158 |
0.0157 |
| 236 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME |
78 |
0.0156 |
| 237 |
INCREASED BRONCHIAL SECRETION |
40 |
0.0156 |
| 238 |
HYPERCAPNIA |
47 |
0.0156 |
| 239 |
HYPERBILIRUBINAEMIA |
161 |
0.0155 |
| 240 |
CYTOKINE RELEASE SYNDROME |
311 |
0.0155 |
| 241 |
TUMOUR LYSIS SYNDROME |
136 |
0.0154 |
| 242 |
PRODUCT DEPOSIT |
24 |
0.0154 |
| 243 |
EPSTEIN-BARR VIRUS INFECTION REACTIVATION |
20 |
0.0152 |
| 244 |
RESUSCITATION |
25 |
0.0151 |
| 245 |
CYTOMEGALOVIRUS INFECTION |
250 |
0.0150 |
| 246 |
CAPILLARY LEAK SYNDROME |
31 |
0.0150 |
| 247 |
COAGULOPATHY |
246 |
0.0147 |
| 248 |
ANURIA |
127 |
0.0147 |
| 249 |
RESPIRATORY ACIDOSIS |
58 |
0.0147 |
| 250 |
CLOSTRIDIUM DIFFICILE INFECTION |
322 |
0.0147 |
| 251 |
HEPATIC CYTOLYSIS |
186 |
0.0146 |
| 252 |
PANCYTOPENIA |
811 |
0.0145 |
| 253 |
ACUTE RESPIRATORY FAILURE |
279 |
0.0145 |
| 254 |
DRUG ERUPTION |
257 |
0.0145 |
| 255 |
CLOSTRIDIAL INFECTION |
49 |
0.0145 |
| 256 |
BLOOD CULTURE POSITIVE |
43 |
0.0143 |
| 257 |
MULTI-ORGAN FAILURE |
246 |
0.0142 |
| 258 |
SUSPECTED OFF LABEL USE |
64 |
0.0142 |
| 259 |
TACHYPNOEA |
192 |
0.0141 |
| 260 |
EMPYEMA |
28 |
0.0141 |
| 261 |
INTRA-ABDOMINAL HAEMORRHAGE |
33 |
0.0138 |
| 262 |
HEPATIC NECROSIS |
52 |
0.0138 |
| 263 |
HYPERAEMIA |
27 |
0.0137 |
| 264 |
EXFOLIATIVE RASH |
36 |
0.0137 |
| 265 |
CYSTITIS HAEMORRHAGIC |
55 |
0.0136 |
| 266 |
ENCEPHALOPATHY |
333 |
0.0135 |
| 267 |
NEPHROPATHY TOXIC |
152 |
0.0135 |
| 268 |
RESPIRATORY ALKALOSIS |
22 |
0.0135 |
| 269 |
PANCREATITIS NECROTISING |
31 |
0.0135 |
| 270 |
GRAFT VERSUS HOST DISEASE |
96 |
0.0133 |
| 271 |
BILIRUBIN CONJUGATED INCREASED |
31 |
0.0133 |
| 272 |
SEPSIS |
1465 |
0.0131 |
| 273 |
COVID-19 PNEUMONIA |
154 |
0.0130 |
| 274 |
ENCEPHALITIS |
89 |
0.0129 |
| 275 |
CHOLESTASIS |
247 |
0.0129 |
| 276 |
ENDOTRACHEAL INTUBATION |
36 |
0.0128 |
| 277 |
TACHYARRHYTHMIA |
32 |
0.0128 |
| 278 |
VENOOCCLUSIVE DISEASE |
32 |
0.0128 |
| 279 |
BK VIRUS INFECTION |
43 |
0.0127 |
| 280 |
EXTREMITY NECROSIS |
22 |
0.0126 |
| 281 |
CYTOMEGALOVIRUS COLITIS |
29 |
0.0126 |
| 282 |
SHOCK |
289 |
0.0126 |
| 283 |
VASCULAR DEVICE INFECTION |
57 |
0.0126 |
| 284 |
RETROPERITONEAL HAEMORRHAGE |
31 |
0.0126 |
| 285 |
HYPERTRIGLYCERIDAEMIA |
73 |
0.0125 |
| 286 |
DRUG LEVEL DECREASED |
125 |
0.0123 |
| 287 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
123 |
0.0122 |
| 288 |
ACUTE GRAFT VERSUS HOST DISEASE |
56 |
0.0122 |
| 289 |
LEUKOCYTOSIS |
221 |
0.0122 |
| 290 |
WOUND DEHISCENCE |
41 |
0.0121 |
| 291 |
INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS |
66 |
0.0121 |
| 292 |
BACTERIAL TEST POSITIVE |
27 |
0.0121 |
| 293 |
SYSTEMIC INFECTION |
20 |
0.0121 |
| 294 |
INTESTINAL ISCHAEMIA |
66 |
0.0120 |
| 295 |
HEPATIC FUNCTION ABNORMAL |
445 |
0.0119 |
| 296 |
DISTRIBUTIVE SHOCK |
27 |
0.0119 |
| 297 |
DRUG-INDUCED LIVER INJURY |
374 |
0.0119 |
| 298 |
CEREBELLAR INFARCTION |
20 |
0.0118 |
| 299 |
TRANSPLANT DYSFUNCTION |
21 |
0.0118 |
| 300 |
BRAIN OEDEMA |
148 |
0.0117 |
| 301 |
ACUTE LYMPHOCYTIC LEUKAEMIA |
33 |
0.0116 |
| 302 |
POTENTIATING DRUG INTERACTION |
39 |
0.0116 |
| 303 |
BONE MARROW FAILURE |
234 |
0.0115 |
| 304 |
HYPERAMMONAEMIC ENCEPHALOPATHY |
20 |
0.0115 |
| 305 |
HYPOXIA |
405 |
0.0115 |
| 306 |
SOFT TISSUE INFECTION |
21 |
0.0115 |
| 307 |
BLOOD ALBUMIN DECREASED |
91 |
0.0115 |
| 308 |
CHOLANGITIS |
71 |
0.0114 |
| 309 |
QUADRIPARESIS |
19 |
0.0114 |
| 310 |
ACUTE MYELOID LEUKAEMIA |
178 |
0.0114 |
| 311 |
ESCHERICHIA SEPSIS |
33 |
0.0114 |
| 312 |
MENINGITIS |
76 |
0.0114 |
| 313 |
LUNG INFILTRATION |
100 |
0.0113 |
| 314 |
HEPATORENAL SYNDROME |
19 |
0.0112 |
| 315 |
DEAFNESS NEUROSENSORY |
37 |
0.0112 |
| 316 |
NEUROLOGICAL DECOMPENSATION |
26 |
0.0112 |
| 317 |
PYELONEPHRITIS ACUTE |
22 |
0.0112 |
| 318 |
ACIDOSIS |
85 |
0.0111 |
| 319 |
C-REACTIVE PROTEIN INCREASED |
401 |
0.0110 |
| 320 |
METABOLIC ENCEPHALOPATHY |
33 |
0.0110 |
| 321 |
SKIN NECROSIS |
57 |
0.0110 |
| 322 |
THROMBOTIC MICROANGIOPATHY |
107 |
0.0110 |
| 323 |
THROMBOCYTOPENIA |
1222 |
0.0109 |
| 324 |
HERPES SIMPLEX |
71 |
0.0109 |
| 325 |
DEVICE RELATED INFECTION |
168 |
0.0109 |
| 326 |
SPLENIC INFARCTION |
19 |
0.0109 |
| 327 |
LONG QT SYNDROME |
26 |
0.0108 |
| 328 |
HYDROCEPHALUS |
59 |
0.0108 |
| 329 |
CHEST X-RAY ABNORMAL |
33 |
0.0108 |
| 330 |
GASTROINTESTINAL OEDEMA |
19 |
0.0107 |
| 331 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
589 |
0.0107 |
| 332 |
HEPATOMEGALY |
105 |
0.0107 |
| 333 |
ATELECTASIS |
103 |
0.0106 |
| 334 |
THROMBOCYTOSIS |
39 |
0.0106 |
| 335 |
DERMATITIS EXFOLIATIVE |
53 |
0.0106 |
| 336 |
NEUROTOXICITY |
185 |
0.0105 |
| 337 |
PULSELESS ELECTRICAL ACTIVITY |
44 |
0.0105 |
| 338 |
ELECTROENCEPHALOGRAM ABNORMAL |
33 |
0.0104 |
| 339 |
HYPERPYREXIA |
44 |
0.0104 |
| 340 |
HEPATOTOXICITY |
231 |
0.0104 |
| 341 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
99 |
0.0104 |
| 342 |
PROTEIN TOTAL DECREASED |
39 |
0.0103 |
| 343 |
STEVENS-JOHNSON SYNDROME |
230 |
0.0103 |
| 344 |
DRUG LEVEL INCREASED |
171 |
0.0103 |
| 345 |
ACUTE HEPATIC FAILURE |
141 |
0.0103 |
| 346 |
BACTERIAL INFECTION |
192 |
0.0103 |
| 347 |
GRANULOCYTE COUNT DECREASED |
19 |
0.0102 |
| 348 |
SERUM FERRITIN INCREASED |
54 |
0.0102 |
| 349 |
HYPOVOLAEMIC SHOCK |
49 |
0.0102 |
| 350 |
CARDIAC FAILURE ACUTE |
68 |
0.0102 |
| 351 |
EOSINOPHIL COUNT INCREASED |
85 |
0.0102 |
| 352 |
PNEUMOTHORAX |
161 |
0.0101 |
| 353 |
ELECTROLYTE IMBALANCE |
117 |
0.0101 |
| 354 |
PULMONARY ALVEOLAR HAEMORRHAGE |
56 |
0.0100 |
| 355 |
LOW BIRTH WEIGHT BABY |
79 |
0.0099 |
| 356 |
EPSTEIN-BARR VIRUS INFECTION |
62 |
0.0099 |
| 357 |
FAECES PALE |
22 |
0.0099 |
| 358 |
ACUTE FEBRILE NEUTROPHILIC DERMATOSIS |
23 |
0.0099 |
| 359 |
HEPATIC FAILURE |
298 |
0.0099 |
| 360 |
FEBRILE BONE MARROW APLASIA |
42 |
0.0099 |
| 361 |
ESCHERICHIA URINARY TRACT INFECTION |
42 |
0.0099 |
| 362 |
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
32 |
0.0098 |
| 363 |
TUBULOINTERSTITIAL NEPHRITIS |
184 |
0.0098 |
| 364 |
DERMATITIS BULLOUS |
71 |
0.0098 |
| 365 |
DRUG LEVEL BELOW THERAPEUTIC |
54 |
0.0098 |
| 366 |
DISSEMINATED TUBERCULOSIS |
25 |
0.0097 |
| 367 |
PANCREATITIS CHRONIC |
23 |
0.0097 |
| 368 |
COMPLICATIONS OF TRANSPLANTED KIDNEY |
22 |
0.0097 |
| 369 |
COMA SCALE ABNORMAL |
28 |
0.0097 |
| 370 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
153 |
0.0096 |
| 371 |
HEPATITIS TOXIC |
25 |
0.0096 |
| 372 |
LEUKOPENIA |
477 |
0.0095 |
| 373 |
AMYLASE INCREASED |
35 |
0.0095 |
| 374 |
MYELOSUPPRESSION |
339 |
0.0094 |
| 375 |
BRAIN DEATH |
29 |
0.0094 |
| 376 |
TRANSPLANT FAILURE |
23 |
0.0094 |
| 377 |
PREMATURE DELIVERY |
149 |
0.0093 |
| 378 |
HYPOPHOSPHATAEMIA |
69 |
0.0093 |
| 379 |
CIRCULATORY COLLAPSE |
158 |
0.0093 |
| 380 |
INTRAVENTRICULAR HAEMORRHAGE |
23 |
0.0092 |
| 381 |
HYPERAMMONAEMIA |
46 |
0.0092 |
| 382 |
NECROSIS |
51 |
0.0092 |
| 383 |
CLONUS |
25 |
0.0091 |
| 384 |
ABDOMINAL INFECTION |
23 |
0.0090 |
| 385 |
ILEUS PARALYTIC |
40 |
0.0090 |
| 386 |
ORGAN FAILURE |
36 |
0.0089 |
| 387 |
ACUTE KIDNEY INJURY |
1360 |
0.0089 |
| 388 |
RENAL TUBULAR DISORDER |
25 |
0.0089 |
| 389 |
FUNGAL INFECTION |
294 |
0.0088 |
| 390 |
HEPARIN-INDUCED THROMBOCYTOPENIA |
43 |
0.0087 |
| 391 |
STAPHYLOCOCCAL INFECTION |
287 |
0.0087 |
| 392 |
BLOOD BILIRUBIN INCREASED |
235 |
0.0087 |
| 393 |
ORGANISING PNEUMONIA |
43 |
0.0087 |
| 394 |
ELECTROCARDIOGRAM ST SEGMENT DEPRESSION |
19 |
0.0086 |
| 395 |
METABOLIC ACIDOSIS |
275 |
0.0086 |
| 396 |
MUCOSAL INFLAMMATION |
225 |
0.0086 |
| 397 |
CYTOPENIA |
105 |
0.0086 |
| 398 |
PROTHROMBIN TIME PROLONGED |
51 |
0.0085 |
| 399 |
HYPERTHERMIA |
65 |
0.0085 |
| 400 |
JAUNDICE CHOLESTATIC |
30 |
0.0085 |
| 401 |
CUTANEOUS VASCULITIS |
31 |
0.0085 |
| 402 |
OTITIS MEDIA |
28 |
0.0085 |
| 403 |
FIBRIN D DIMER INCREASED |
30 |
0.0084 |
| 404 |
SUBDURAL HAEMORRHAGE |
23 |
0.0084 |
| 405 |
HYPOXIC-ISCHAEMIC ENCEPHALOPATHY |
22 |
0.0084 |
| 406 |
PORTAL VEIN THROMBOSIS |
27 |
0.0083 |
| 407 |
POLYNEUROPATHY |
100 |
0.0083 |
| 408 |
TRANSAMINASES INCREASED |
185 |
0.0083 |
| 409 |
IMMUNE THROMBOCYTOPENIA |
38 |
0.0083 |
| 410 |
HYPOKALAEMIA |
383 |
0.0083 |
| 411 |
METABOLIC DISORDER |
48 |
0.0083 |
| 412 |
SERUM SICKNESS |
23 |
0.0082 |
| 413 |
LIVER INJURY |
202 |
0.0082 |
| 414 |
RHINOVIRUS INFECTION |
32 |
0.0082 |
| 415 |
AUTOIMMUNE HAEMOLYTIC ANAEMIA |
28 |
0.0082 |
| 416 |
HAEMOLYSIS |
63 |
0.0082 |
| 417 |
STATUS EPILEPTICUS |
92 |
0.0081 |
| 418 |
GUILLAIN-BARRE SYNDROME |
39 |
0.0081 |
| 419 |
HYPERURICAEMIA |
33 |
0.0080 |
| 420 |
RESPIRATORY DISTRESS |
221 |
0.0080 |
| 421 |
GENERALISED OEDEMA |
99 |
0.0080 |
| 422 |
LUNG OPACITY |
21 |
0.0080 |
| 423 |
ELECTROCARDIOGRAM QT PROLONGED |
286 |
0.0079 |
| 424 |
CARDIOPULMONARY FAILURE |
31 |
0.0079 |
| 425 |
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER |
40 |
0.0079 |
| 426 |
MYCOBACTERIUM AVIUM COMPLEX INFECTION |
21 |
0.0078 |
| 427 |
RENAL IMPAIRMENT |
651 |
0.0077 |
| 428 |
MALNUTRITION |
86 |
0.0077 |
| 429 |
LARGE INTESTINE PERFORATION |
53 |
0.0076 |
| 430 |
TRANSPLANT REJECTION |
61 |
0.0076 |
| 431 |
IMMUNOSUPPRESSION |
67 |
0.0076 |
| 432 |
EPILEPSY |
232 |
0.0076 |
| 433 |
MACULE |
21 |
0.0076 |
| 434 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
127 |
0.0075 |
| 435 |
STREPTOCOCCAL INFECTION |
42 |
0.0075 |
| 436 |
GASTROINTESTINAL NECROSIS |
22 |
0.0075 |
| 437 |
RENAL TUBULAR NECROSIS |
74 |
0.0075 |
| 438 |
BLOOD UREA INCREASED |
126 |
0.0075 |
| 439 |
FOETAL DEATH |
39 |
0.0075 |
| 440 |
KIDNEY TRANSPLANT REJECTION |
36 |
0.0075 |
| 441 |
HYPOGAMMAGLOBULINAEMIA |
49 |
0.0075 |
| 442 |
DISEASE COMPLICATION |
34 |
0.0074 |
| 443 |
HEPATOCELLULAR INJURY |
105 |
0.0074 |
| 444 |
OXYGEN SATURATION ABNORMAL |
21 |
0.0074 |
| 445 |
CACHEXIA |
38 |
0.0074 |
| 446 |
CEREBRAL ISCHAEMIA |
38 |
0.0074 |
| 447 |
PETECHIAE |
77 |
0.0074 |
| 448 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
183 |
0.0074 |
| 449 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
163 |
0.0073 |
| 450 |
NEUTROPENIA |
997 |
0.0073 |
| 451 |
GENERALISED TONIC-CLONIC SEIZURE |
121 |
0.0073 |
| 452 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
37 |
0.0073 |
| 453 |
ASCITES |
214 |
0.0073 |
| 454 |
OESOPHAGEAL CANDIDIASIS |
29 |
0.0073 |
| 455 |
LEUKOENCEPHALOPATHY |
27 |
0.0072 |
| 456 |
HYPERSENSITIVITY VASCULITIS |
19 |
0.0072 |
| 457 |
CHOLECYSTITIS ACUTE |
41 |
0.0072 |
| 458 |
RALES |
42 |
0.0072 |
| 459 |
CYSTIC FIBROSIS |
40 |
0.0072 |
| 460 |
ORAL CANDIDIASIS |
95 |
0.0072 |
| 461 |
AREFLEXIA |
19 |
0.0071 |
| 462 |
SUBCUTANEOUS ABSCESS |
34 |
0.0071 |
| 463 |
HEPATITIS ACUTE |
46 |
0.0071 |
| 464 |
PANCREATITIS ACUTE |
159 |
0.0071 |
| 465 |
ALANINE AMINOTRANSFERASE INCREASED |
434 |
0.0071 |
| 466 |
HAEMORRHAGIC DIATHESIS |
25 |
0.0070 |
| 467 |
HYPOTONIA |
70 |
0.0070 |
| 468 |
AZOTAEMIA |
28 |
0.0070 |
| 469 |
ACUTE PULMONARY OEDEMA |
39 |
0.0069 |
| 470 |
CARDIAC ARREST |
573 |
0.0069 |
| 471 |
PNEUMONIA ASPIRATION |
173 |
0.0069 |
| 472 |
HAEMOTHORAX |
20 |
0.0069 |
| 473 |
NEPHRITIS |
23 |
0.0069 |
| 474 |
MYOCLONUS |
82 |
0.0069 |
| 475 |
VENTRICULAR HYPOKINESIA |
22 |
0.0068 |
| 476 |
ABDOMINAL ABSCESS |
30 |
0.0068 |
| 477 |
HYPERKALAEMIA |
238 |
0.0068 |
| 478 |
ALTERED STATE OF CONSCIOUSNESS |
146 |
0.0067 |
| 479 |
UROSEPSIS |
62 |
0.0067 |
| 480 |
BRONCHOPNEUMONIA |
23 |
0.0067 |
| 481 |
ODYNOPHAGIA |
40 |
0.0067 |
| 482 |
HAEMORRHAGE INTRACRANIAL |
100 |
0.0067 |
| 483 |
NEUTROPHIL COUNT DECREASED |
272 |
0.0067 |
| 484 |
PLEURAL EFFUSION |
406 |
0.0067 |
| 485 |
PYREXIA |
2302 |
0.0066 |
| 486 |
BLOOD LACTIC ACID INCREASED |
35 |
0.0066 |
| 487 |
CONCOMITANT DISEASE AGGRAVATED |
41 |
0.0066 |
| 488 |
PNEUMONIA VIRAL |
21 |
0.0066 |
| 489 |
LYMPHOPENIA |
93 |
0.0066 |
| 490 |
PERITONITIS |
136 |
0.0066 |
| 491 |
CEREBRAL HAEMATOMA |
22 |
0.0065 |
| 492 |
PARADOXICAL DRUG REACTION |
24 |
0.0065 |
| 493 |
ABSCESS |
104 |
0.0065 |
| 494 |
DELIRIUM |
226 |
0.0065 |
| 495 |
PARTIAL SEIZURES |
34 |
0.0065 |
| 496 |
DRUG INTERACTION |
1029 |
0.0065 |
| 497 |
CANDIDIASIS |
26 |
0.0065 |
| 498 |
ASPARTATE AMINOTRANSFERASE INCREASED |
342 |
0.0064 |
| 499 |
LACTIC ACIDOSIS |
207 |
0.0064 |
| 500 |
PROCTALGIA |
41 |
0.0064 |
| 501 |
ARTHRITIS BACTERIAL |
26 |
0.0063 |
| 502 |
PURULENT DISCHARGE |
27 |
0.0063 |
| 503 |
PULMONARY TUBERCULOSIS |
27 |
0.0063 |
| 504 |
CARDIAC TAMPONADE |
30 |
0.0063 |
| 505 |
URINE OUTPUT DECREASED |
55 |
0.0063 |
| 506 |
THROMBOTIC THROMBOCYTOPENIC PURPURA |
22 |
0.0062 |
| 507 |
STUPOR |
20 |
0.0062 |
| 508 |
SINUS TACHYCARDIA |
88 |
0.0062 |
| 509 |
DRUG LEVEL ABOVE THERAPEUTIC |
28 |
0.0061 |
| 510 |
PURPURA |
54 |
0.0061 |
| 511 |
HEPATITIS |
156 |
0.0061 |
| 512 |
PREMATURE BABY |
183 |
0.0061 |
| 513 |
PYELONEPHRITIS |
52 |
0.0060 |
| 514 |
BLOOD CREATININE INCREASED |
391 |
0.0060 |
| 515 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
236 |
0.0060 |
| 516 |
NEUROLOGICAL SYMPTOM |
34 |
0.0059 |
| 517 |
EMBOLISM |
49 |
0.0059 |
| 518 |
BODY TEMPERATURE INCREASED |
120 |
0.0059 |
| 519 |
DEMYELINATION |
24 |
0.0059 |
| 520 |
CARDIOGENIC SHOCK |
84 |
0.0058 |
| 521 |
EXTRAVASATION |
24 |
0.0058 |
| 522 |
SPLENOMEGALY |
68 |
0.0058 |
| 523 |
THERAPY NON-RESPONDER |
260 |
0.0058 |
| 524 |
BREATH SOUNDS ABNORMAL |
28 |
0.0057 |
| 525 |
OESOPHAGITIS |
62 |
0.0057 |
| 526 |
PLATELET COUNT DECREASED |
601 |
0.0056 |
| 527 |
LYMPHOCYTE COUNT DECREASED |
99 |
0.0056 |
| 528 |
HEPATIC ENCEPHALOPATHY |
52 |
0.0056 |
| 529 |
NEUROLEPTIC MALIGNANT SYNDROME |
66 |
0.0056 |
| 530 |
PYODERMA GANGRENOSUM |
20 |
0.0056 |
| 531 |
ILEUS |
69 |
0.0055 |
| 532 |
HEPATIC LESION |
24 |
0.0055 |
| 533 |
PERICARDIAL EFFUSION |
128 |
0.0055 |
| 534 |
LIVER FUNCTION TEST ABNORMAL |
161 |
0.0055 |
| 535 |
APLASIA PURE RED CELL |
19 |
0.0055 |
| 536 |
VENTRICULAR FIBRILLATION |
61 |
0.0055 |
| 537 |
TORSADE DE POINTES |
43 |
0.0055 |
| 538 |
DIFFUSE LARGE B-CELL LYMPHOMA |
42 |
0.0054 |
| 539 |
FUNGAL SKIN INFECTION |
22 |
0.0054 |
| 540 |
RENAL FAILURE |
723 |
0.0054 |
| 541 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
40 |
0.0054 |
| 542 |
LUNG INFECTION |
84 |
0.0054 |
| 543 |
EJECTION FRACTION DECREASED |
84 |
0.0054 |
| 544 |
BRONCHOSPASM |
77 |
0.0054 |
| 545 |
WHITE BLOOD CELL COUNT INCREASED |
207 |
0.0054 |
| 546 |
NEUTROPHIL COUNT INCREASED |
55 |
0.0054 |
| 547 |
SEROTONIN SYNDROME |
103 |
0.0054 |
| 548 |
PNEUMONITIS |
146 |
0.0054 |
| 549 |
MYOSITIS |
48 |
0.0053 |
| 550 |
ENTERITIS |
34 |
0.0053 |
| 551 |
HAEMOPTYSIS |
148 |
0.0053 |
| 552 |
PLATELET COUNT INCREASED |
69 |
0.0053 |
| 553 |
HYPERVOLAEMIA |
26 |
0.0053 |
| 554 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
32 |
0.0053 |
| 555 |
SUBARACHNOID HAEMORRHAGE |
53 |
0.0052 |
| 556 |
COLITIS ISCHAEMIC |
35 |
0.0052 |
| 557 |
POSTOPERATIVE WOUND INFECTION |
35 |
0.0052 |
| 558 |
HYPOCALCAEMIA |
98 |
0.0052 |
| 559 |
ANAEMIA |
986 |
0.0052 |
| 560 |
PERIPHERAL ISCHAEMIA |
21 |
0.0051 |
| 561 |
HAEMOLYTIC ANAEMIA |
46 |
0.0051 |
| 562 |
MYOPATHY |
44 |
0.0051 |
| 563 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
45 |
0.0051 |
| 564 |
LEFT VENTRICULAR DYSFUNCTION |
34 |
0.0051 |
| 565 |
OCULAR ICTERUS |
22 |
0.0051 |
| 566 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
44 |
0.0050 |
| 567 |
RESPIRATORY DISORDER |
151 |
0.0050 |
| 568 |
ANAL ABSCESS |
27 |
0.0050 |
| 569 |
DUODENAL ULCER |
35 |
0.0050 |
| 570 |
RHABDOMYOLYSIS |
206 |
0.0049 |
| 571 |
INTERSTITIAL LUNG DISEASE |
239 |
0.0049 |
| 572 |
ABSCESS LIMB |
21 |
0.0049 |
| 573 |
SUPRAVENTRICULAR TACHYCARDIA |
47 |
0.0049 |
| 574 |
HAEMODIALYSIS |
41 |
0.0049 |
| 575 |
PNEUMONIA |
1551 |
0.0048 |
| 576 |
ISCHAEMIA |
22 |
0.0048 |
| 577 |
DECUBITUS ULCER |
39 |
0.0048 |
| 578 |
GRANULOCYTOPENIA |
27 |
0.0047 |
| 579 |
GASTRITIS EROSIVE |
22 |
0.0047 |
| 580 |
OSTEOMYELITIS |
85 |
0.0047 |
| 581 |
DERMATITIS ALLERGIC |
59 |
0.0047 |
| 582 |
UNRESPONSIVE TO STIMULI |
120 |
0.0046 |
| 583 |
MENTAL STATUS CHANGES |
129 |
0.0046 |
| 584 |
PROTEIN URINE PRESENT |
23 |
0.0046 |
| 585 |
HYPOMAGNESAEMIA |
64 |
0.0046 |
| 586 |
VENTRICULAR TACHYCARDIA |
75 |
0.0045 |
| 587 |
JAUNDICE |
122 |
0.0045 |
| 588 |
ARTHRITIS INFECTIVE |
21 |
0.0045 |
| 589 |
CEREBRAL INFARCTION |
110 |
0.0045 |
| 590 |
DISEASE PROGRESSION |
532 |
0.0045 |
| 591 |
HYPOTENSION |
896 |
0.0045 |
| 592 |
ADRENAL INSUFFICIENCY |
54 |
0.0044 |
| 593 |
MYOCARDITIS |
51 |
0.0044 |
| 594 |
PULMONARY MASS |
66 |
0.0044 |
| 595 |
HEMIPARESIS |
75 |
0.0044 |
| 596 |
CHRONIC LYMPHOCYTIC LEUKAEMIA |
21 |
0.0044 |
| 597 |
CONDITION AGGRAVATED |
1341 |
0.0044 |
| 598 |
TACHYCARDIA |
391 |
0.0044 |
| 599 |
RESPIRATORY RATE INCREASED |
39 |
0.0044 |
| 600 |
TREATMENT FAILURE |
362 |
0.0044 |
| 601 |
BUNDLE BRANCH BLOCK RIGHT |
20 |
0.0044 |
| 602 |
PULMONARY OEDEMA |
195 |
0.0044 |
| 603 |
GLOMERULAR FILTRATION RATE DECREASED |
53 |
0.0043 |
| 604 |
LIVER DISORDER |
191 |
0.0043 |
| 605 |
GINGIVAL SWELLING |
19 |
0.0043 |
| 606 |
ERYTHEMA MULTIFORME |
40 |
0.0043 |
| 607 |
RENAL FAILURE ACUTE |
181 |
0.0043 |
| 608 |
HYPOTHERMIA |
43 |
0.0042 |
| 609 |
INTERNATIONAL NORMALISED RATIO INCREASED |
121 |
0.0042 |
| 610 |
APNOEA |
33 |
0.0042 |
| 611 |
MELAENA |
93 |
0.0042 |
| 612 |
HYPONATRAEMIA |
238 |
0.0042 |
| 613 |
GASTROINTESTINAL TOXICITY |
20 |
0.0042 |
| 614 |
HYDRONEPHROSIS |
31 |
0.0041 |
| 615 |
STILLBIRTH |
20 |
0.0041 |
| 616 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
119 |
0.0041 |
| 617 |
INTRACRANIAL PRESSURE INCREASED |
23 |
0.0041 |
| 618 |
PAPULE |
29 |
0.0041 |
| 619 |
RESPIRATORY TRACT INFECTION |
107 |
0.0041 |
| 620 |
ACUTE CORONARY SYNDROME |
34 |
0.0041 |
| 621 |
GASTROINTESTINAL HAEMORRHAGE |
343 |
0.0041 |
| 622 |
FACE OEDEMA |
69 |
0.0041 |
| 623 |
HAEMATOMA |
105 |
0.0040 |
| 624 |
FAILURE TO THRIVE |
21 |
0.0040 |
| 625 |
OFF LABEL USE |
3521 |
0.0040 |
| 626 |
GENERAL PHYSICAL HEALTH DETERIORATION |
463 |
0.0040 |
| 627 |
RASH VESICULAR |
19 |
0.0039 |
| 628 |
ASPIRATION |
43 |
0.0039 |
| 629 |
MOTOR DYSFUNCTION |
40 |
0.0039 |
| 630 |
LIPASE INCREASED |
30 |
0.0039 |
| 631 |
NERVOUS SYSTEM DISORDER |
122 |
0.0039 |
| 632 |
COLITIS |
148 |
0.0039 |
| 633 |
INFECTION |
564 |
0.0039 |
| 634 |
BRAIN INJURY |
39 |
0.0039 |
| 635 |
BENIGN PROSTATIC HYPERPLASIA |
20 |
0.0039 |
| 636 |
PULMONARY CONGESTION |
51 |
0.0039 |
| 637 |
NEUTROPHILIA |
22 |
0.0039 |
| 638 |
OXYGEN SATURATION DECREASED |
217 |
0.0039 |
| 639 |
CARDIOTOXICITY |
34 |
0.0038 |
| 640 |
HAEMOGLOBIN DECREASED |
391 |
0.0038 |
| 641 |
CHOLECYSTITIS |
45 |
0.0038 |
| 642 |
HYPOVOLAEMIA |
22 |
0.0038 |
| 643 |
LYMPHOEDEMA |
26 |
0.0038 |
| 644 |
WHITE BLOOD CELL COUNT DECREASED |
403 |
0.0037 |
| 645 |
BRONCHIECTASIS |
25 |
0.0037 |
| 646 |
GASTROENTERITIS |
54 |
0.0037 |
| 647 |
CARDIAC FAILURE |
297 |
0.0037 |
| 648 |
VASCULITIS |
43 |
0.0037 |
| 649 |
INTESTINAL PERFORATION |
41 |
0.0036 |
| 650 |
PRODUCT USE IN UNAPPROVED INDICATION |
904 |
0.0036 |
| 651 |
DRUG INEFFECTIVE |
4797 |
0.0036 |
| 652 |
HAEMATOCRIT DECREASED |
71 |
0.0036 |
| 653 |
RASH PUSTULAR |
26 |
0.0036 |
| 654 |
HYPERCHLORHYDRIA |
21 |
0.0036 |
| 655 |
TROPONIN INCREASED |
27 |
0.0035 |
| 656 |
ORAL DISORDER |
26 |
0.0035 |
| 657 |
OEDEMA |
192 |
0.0035 |
| 658 |
PANCREATITIS |
187 |
0.0035 |
| 659 |
HAEMATURIA |
121 |
0.0035 |
| 660 |
CELLULITIS |
178 |
0.0035 |
| 661 |
CEREBRAL HAEMORRHAGE |
126 |
0.0035 |
| 662 |
CARDIO-RESPIRATORY ARREST |
147 |
0.0035 |
| 663 |
BRADYCARDIA |
186 |
0.0035 |
| 664 |
ECCHYMOSIS |
24 |
0.0035 |
| 665 |
SEIZURE |
402 |
0.0035 |
| 666 |
ATRIAL FIBRILLATION |
337 |
0.0035 |
| 667 |
STRESS CARDIOMYOPATHY |
20 |
0.0034 |
| 668 |
CYANOSIS |
54 |
0.0034 |
| 669 |
HYPERGLYCAEMIA |
124 |
0.0034 |
| 670 |
FACIAL PARALYSIS |
29 |
0.0034 |
| 671 |
EXPOSURE DURING PREGNANCY |
210 |
0.0034 |
| 672 |
RESPIRATORY ARREST |
93 |
0.0034 |
| 673 |
RASH ERYTHEMATOUS |
161 |
0.0034 |
| 674 |
CARDIOMEGALY |
41 |
0.0033 |
| 675 |
MYELODYSPLASTIC SYNDROME |
48 |
0.0033 |
| 676 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
34 |
0.0033 |
| 677 |
RIGHT VENTRICULAR FAILURE |
23 |
0.0033 |
| 678 |
TENDERNESS |
34 |
0.0033 |
| 679 |
PULMONARY TOXICITY |
23 |
0.0032 |
| 680 |
PERIPHERAL SENSORY NEUROPATHY |
19 |
0.0032 |
| 681 |
SCOLIOSIS |
20 |
0.0032 |
| 682 |
HEPATIC ENZYME INCREASED |
220 |
0.0032 |
| 683 |
COMA |
153 |
0.0032 |
| 684 |
PLEURISY |
19 |
0.0032 |
| 685 |
ABNORMAL FAECES |
26 |
0.0032 |
| 686 |
LYMPHADENOPATHY |
112 |
0.0032 |
| 687 |
TRANSFUSION |
33 |
0.0031 |
| 688 |
FOETAL GROWTH RESTRICTION |
19 |
0.0031 |
| 689 |
NEPHROPATHY |
29 |
0.0031 |
| 690 |
PROTEINURIA |
59 |
0.0031 |
| 691 |
FLANK PAIN |
29 |
0.0031 |
| 692 |
SKIN HYPERPIGMENTATION |
26 |
0.0030 |
| 693 |
RED BLOOD CELL COUNT DECREASED |
86 |
0.0030 |
| 694 |
SINUS BRADYCARDIA |
29 |
0.0030 |
| 695 |
MIOSIS |
24 |
0.0030 |
| 696 |
MOUTH ULCERATION |
63 |
0.0030 |
| 697 |
SECRETION DISCHARGE |
37 |
0.0030 |
| 698 |
HYPERCALCAEMIA |
36 |
0.0029 |
| 699 |
ANAPHYLACTIC SHOCK |
75 |
0.0029 |
| 700 |
MATERNAL EXPOSURE DURING PREGNANCY |
259 |
0.0029 |
| 701 |
FLUID OVERLOAD |
42 |
0.0029 |
| 702 |
LOWER RESPIRATORY TRACT INFECTION |
131 |
0.0029 |
| 703 |
PULMONARY FIBROSIS |
55 |
0.0029 |
| 704 |
SKIN LESION |
77 |
0.0028 |
| 705 |
APPENDICITIS |
26 |
0.0028 |
| 706 |
ACCIDENT |
33 |
0.0028 |
| 707 |
RENAL INJURY |
82 |
0.0028 |
| 708 |
ATRIAL FLUTTER |
22 |
0.0028 |
| 709 |
FOETAL EXPOSURE DURING PREGNANCY |
223 |
0.0027 |
| 710 |
ANAPHYLACTIC REACTION |
151 |
0.0027 |
| 711 |
LYMPHOMA |
42 |
0.0027 |
| 712 |
CENTRAL NERVOUS SYSTEM LESION |
37 |
0.0027 |
| 713 |
PULMONARY HYPERTENSION |
56 |
0.0027 |
| 714 |
MITRAL VALVE INCOMPETENCE |
30 |
0.0026 |
| 715 |
BLOOD POTASSIUM INCREASED |
43 |
0.0026 |
| 716 |
CARDIOMYOPATHY |
39 |
0.0026 |
| 717 |
BLOOD PRESSURE DECREASED |
174 |
0.0026 |
| 718 |
INFLAMMATION |
135 |
0.0026 |
| 719 |
CONTRAINDICATED PRODUCT ADMINISTERED |
79 |
0.0026 |
| 720 |
DIALYSIS |
37 |
0.0026 |
| 721 |
MUSCLE ATROPHY |
33 |
0.0026 |
| 722 |
HALLUCINATION, VISUAL |
54 |
0.0026 |
| 723 |
SUBDURAL HAEMATOMA |
36 |
0.0025 |
| 724 |
SKIN ULCER |
65 |
0.0025 |
| 725 |
MYASTHENIA GRAVIS |
20 |
0.0025 |
| 726 |
HYPOGLYCAEMIA |
120 |
0.0025 |
| 727 |
CHILLS |
290 |
0.0025 |
| 728 |
LETHARGY |
142 |
0.0025 |
| 729 |
NO THERAPEUTIC RESPONSE |
30 |
0.0025 |
| 730 |
ATAXIA |
29 |
0.0024 |
| 731 |
POLYURIA |
20 |
0.0024 |
| 732 |
TOXICITY TO VARIOUS AGENTS |
411 |
0.0024 |
| 733 |
CHROMATURIA |
55 |
0.0024 |
| 734 |
IMMUNODEFICIENCY |
36 |
0.0024 |
| 735 |
HAEMORRHOIDS |
47 |
0.0024 |
| 736 |
ORAL HERPES |
47 |
0.0024 |
| 737 |
PALLOR |
65 |
0.0024 |
| 738 |
DISEASE RECURRENCE |
113 |
0.0024 |
| 739 |
LIVER FUNCTION TEST INCREASED |
51 |
0.0024 |
| 740 |
DEAFNESS |
62 |
0.0024 |
| 741 |
TOOTH INFECTION |
31 |
0.0023 |
| 742 |
ARTERIOSCLEROSIS |
22 |
0.0023 |
| 743 |
HYPERTENSIVE CRISIS |
26 |
0.0023 |
| 744 |
LUNG DISORDER |
113 |
0.0023 |
| 745 |
URINARY TRACT INFECTION |
392 |
0.0023 |
| 746 |
RENAL DISORDER |
107 |
0.0023 |
| 747 |
PERITONITIS BACTERIAL |
23 |
0.0023 |
| 748 |
NEUROPATHY PERIPHERAL |
212 |
0.0022 |
| 749 |
VENTRICULAR EXTRASYSTOLES |
23 |
0.0022 |
| 750 |
CONFUSIONAL STATE |
357 |
0.0022 |
| 751 |
INTRAOCULAR PRESSURE INCREASED |
28 |
0.0022 |
| 752 |
BLISTER |
123 |
0.0022 |
| 753 |
HAEMATEMESIS |
55 |
0.0022 |
| 754 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
152 |
0.0021 |
| 755 |
ACUTE MYOCARDIAL INFARCTION |
62 |
0.0021 |
| 756 |
JOINT DISLOCATION |
22 |
0.0021 |
| 757 |
DERMATITIS |
43 |
0.0021 |
| 758 |
PULMONARY EMBOLISM |
194 |
0.0020 |
| 759 |
HEPATIC STEATOSIS |
38 |
0.0020 |
| 760 |
HYPOPHAGIA |
52 |
0.0020 |
| 761 |
HEPATIC CIRRHOSIS |
38 |
0.0020 |
| 762 |
BLOOD SODIUM DECREASED |
38 |
0.0020 |
| 763 |
WHEEZING |
119 |
0.0020 |
| 764 |
RASH MACULAR |
70 |
0.0020 |
| 765 |
SKIN REACTION |
28 |
0.0020 |
| 766 |
BLOOD CALCIUM DECREASED |
22 |
0.0020 |
| 767 |
RASH |
848 |
0.0019 |
| 768 |
RASH GENERALISED |
50 |
0.0019 |
| 769 |
DYSPHAGIA |
183 |
0.0019 |
| 770 |
DISORIENTATION |
76 |
0.0019 |
| 771 |
APHASIA |
57 |
0.0019 |
| 772 |
EMPHYSEMA |
19 |
0.0019 |
| 773 |
CONVULSION |
107 |
0.0019 |
| 774 |
MYDRIASIS |
24 |
0.0019 |
| 775 |
REBOUND EFFECT |
21 |
0.0019 |
| 776 |
COVID-19 |
326 |
0.0019 |
| 777 |
MUSCLE RIGIDITY |
22 |
0.0018 |
| 778 |
ABDOMINAL PAIN |
427 |
0.0018 |
| 779 |
DIARRHOEA |
1174 |
0.0018 |
| 780 |
STOMATITIS |
110 |
0.0018 |
| 781 |
PAIN IN JAW |
51 |
0.0018 |
| 782 |
BLOOD POTASSIUM DECREASED |
54 |
0.0018 |
| 783 |
THERAPY PARTIAL RESPONDER |
28 |
0.0018 |
| 784 |
ARRHYTHMIA |
84 |
0.0018 |
| 785 |
GINGIVAL BLEEDING |
24 |
0.0018 |
| 786 |
DEEP VEIN THROMBOSIS |
114 |
0.0018 |
| 787 |
GASTRITIS |
46 |
0.0017 |
| 788 |
PRODUCTIVE COUGH |
83 |
0.0017 |
| 789 |
HALLUCINATION |
131 |
0.0017 |
| 790 |
HYPOTHYROIDISM |
55 |
0.0017 |
| 791 |
FAECES DISCOLOURED |
37 |
0.0017 |
| 792 |
IMPAIRED GASTRIC EMPTYING |
23 |
0.0017 |
| 793 |
CONJUNCTIVITIS |
31 |
0.0017 |
| 794 |
UPPER RESPIRATORY TRACT INFECTION |
75 |
0.0016 |
| 795 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
35 |
0.0016 |
| 796 |
PHARYNGITIS |
20 |
0.0016 |
| 797 |
SKIN EXFOLIATION |
136 |
0.0016 |
| 798 |
MALIGNANT NEOPLASM PROGRESSION |
165 |
0.0016 |
| 799 |
NEOPLASM PROGRESSION |
56 |
0.0016 |
| 800 |
GASTRIC ULCER |
30 |
0.0016 |
| 801 |
VOMITING |
742 |
0.0016 |
| 802 |
EPISTAXIS |
118 |
0.0016 |
| 803 |
INTENTIONAL PRODUCT USE ISSUE |
136 |
0.0016 |
| 804 |
RESPIRATORY DEPRESSION |
19 |
0.0015 |
| 805 |
RASH PRURITIC |
84 |
0.0015 |
| 806 |
MENTAL DISORDER |
67 |
0.0015 |
| 807 |
DYSPNOEA |
871 |
0.0015 |
| 808 |
PRODUCT PRESCRIBING ISSUE |
33 |
0.0015 |
| 809 |
ERYTHEMA |
311 |
0.0015 |
| 810 |
DECREASED APPETITE |
350 |
0.0015 |
| 811 |
PSYCHOMOTOR HYPERACTIVITY |
25 |
0.0015 |
| 812 |
RESTLESSNESS |
55 |
0.0015 |
| 813 |
FULL BLOOD COUNT DECREASED |
30 |
0.0015 |
| 814 |
PERICARDITIS |
25 |
0.0015 |
| 815 |
PRODUCT USE ISSUE |
272 |
0.0014 |
| 816 |
OEDEMA PERIPHERAL |
176 |
0.0014 |
| 817 |
HYPERTENSION |
305 |
0.0014 |
| 818 |
SKIN DISORDER |
48 |
0.0014 |
| 819 |
DYSARTHRIA |
54 |
0.0014 |
| 820 |
CHOLELITHIASIS |
47 |
0.0014 |
| 821 |
HAEMATOCHEZIA |
79 |
0.0014 |
| 822 |
INFUSION RELATED REACTION |
94 |
0.0014 |
| 823 |
BLOOD TRIGLYCERIDES INCREASED |
25 |
0.0014 |
| 824 |
DYSURIA |
52 |
0.0014 |
| 825 |
VISUAL ACUITY REDUCED |
46 |
0.0014 |
| 826 |
HERPES ZOSTER |
79 |
0.0014 |
| 827 |
END STAGE RENAL DISEASE |
25 |
0.0014 |
| 828 |
GASTROINTESTINAL DISORDER |
122 |
0.0014 |
| 829 |
PRESCRIBED OVERDOSE |
26 |
0.0013 |
| 830 |
LOSS OF CONSCIOUSNESS |
172 |
0.0013 |
| 831 |
TREATMENT NONCOMPLIANCE |
73 |
0.0013 |
| 832 |
PHOTOSENSITIVITY REACTION |
22 |
0.0013 |
| 833 |
HAEMORRHAGE |
138 |
0.0013 |
| 834 |
PULMONARY ARTERIAL HYPERTENSION |
19 |
0.0013 |
| 835 |
POST PROCEDURAL COMPLICATION |
25 |
0.0013 |
| 836 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
38 |
0.0013 |
| 837 |
DEHYDRATION |
173 |
0.0013 |
| 838 |
ABDOMINAL DISTENSION |
132 |
0.0013 |
| 839 |
ORTHOSTATIC HYPOTENSION |
22 |
0.0013 |
| 840 |
OSTEONECROSIS OF JAW |
31 |
0.0013 |
| 841 |
ISCHAEMIC STROKE |
22 |
0.0012 |
| 842 |
MUSCULAR WEAKNESS |
140 |
0.0012 |
| 843 |
HYPERSENSITIVITY |
228 |
0.0012 |
| 844 |
INTESTINAL OBSTRUCTION |
46 |
0.0012 |
| 845 |
SEDATION |
31 |
0.0012 |
| 846 |
PLASMA CELL MYELOMA |
46 |
0.0012 |
| 847 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
20 |
0.0012 |
| 848 |
AGITATION |
85 |
0.0012 |
| 849 |
URINARY INCONTINENCE |
34 |
0.0011 |
| 850 |
ANGIOEDEMA |
50 |
0.0011 |
| 851 |
DIABETIC KETOACIDOSIS |
27 |
0.0011 |
| 852 |
COUGH |
312 |
0.0011 |
| 853 |
PRURITUS GENERALISED |
24 |
0.0011 |
| 854 |
TINNITUS |
50 |
0.0011 |
| 855 |
TREMOR |
180 |
0.0011 |
| 856 |
THROMBOSIS |
87 |
0.0011 |
| 857 |
CHRONIC KIDNEY DISEASE |
81 |
0.0011 |
| 858 |
CARDIOVASCULAR DISORDER |
27 |
0.0011 |
| 859 |
OVERDOSE |
227 |
0.0011 |
| 860 |
SOMNOLENCE |
211 |
0.0010 |
| 861 |
MUSCLE TWITCHING |
24 |
0.0010 |
| 862 |
IMPAIRED HEALING |
34 |
0.0010 |
| 863 |
PRESYNCOPE |
25 |
0.0010 |
| 864 |
BRONCHITIS |
76 |
0.0010 |
| 865 |
CONSTIPATION |
222 |
0.0010 |
| 866 |
NAUSEA |
804 |
0.0010 |
| 867 |
CHEST PAIN |
184 |
0.0010 |
| 868 |
ACCIDENTAL OVERDOSE |
36 |
0.0010 |
| 869 |
HYPOACUSIS |
42 |
0.0010 |
| 870 |
BACK PAIN |
225 |
0.0010 |
| 871 |
DISTURBANCE IN ATTENTION |
52 |
0.0010 |
| 872 |
DRUG INTOLERANCE |
93 |
0.0010 |
| 873 |
DYSKINESIA |
39 |
0.0010 |
| 874 |
LABORATORY TEST ABNORMAL |
28 |
0.0009 |
| 875 |
SWELLING FACE |
61 |
0.0009 |
| 876 |
RECTAL HAEMORRHAGE |
40 |
0.0009 |
| 877 |
DYSPNOEA EXERTIONAL |
35 |
0.0009 |
| 878 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
48 |
0.0009 |
| 879 |
ASTHENIA |
337 |
0.0009 |
| 880 |
DIABETES MELLITUS |
67 |
0.0009 |
| 881 |
HEART RATE INCREASED |
87 |
0.0009 |
| 882 |
MALAISE |
378 |
0.0009 |
| 883 |
VIRAL INFECTION |
28 |
0.0008 |
| 884 |
NIGHT SWEATS |
27 |
0.0008 |
| 885 |
VERTIGO |
51 |
0.0008 |
| 886 |
SINUSITIS |
85 |
0.0008 |
| 887 |
DEATH |
703 |
0.0008 |
| 888 |
INFLUENZA |
91 |
0.0008 |
| 889 |
BLINDNESS |
33 |
0.0008 |
| 890 |
WEIGHT DECREASED |
226 |
0.0008 |
| 891 |
URINARY RETENTION |
27 |
0.0008 |
| 892 |
NEPHROLITHIASIS |
37 |
0.0008 |
| 893 |
CHEST DISCOMFORT |
81 |
0.0008 |
| 894 |
PRURITUS |
303 |
0.0008 |
| 895 |
CYSTITIS |
25 |
0.0008 |
| 896 |
LIP SWELLING |
26 |
0.0008 |
| 897 |
PALPITATIONS |
89 |
0.0008 |
| 898 |
SYNCOPE |
76 |
0.0008 |
| 899 |
THERAPEUTIC RESPONSE DECREASED |
46 |
0.0008 |
| 900 |
HYPOAESTHESIA |
113 |
0.0008 |
| 901 |
COGNITIVE DISORDER |
35 |
0.0007 |
| 902 |
URTICARIA |
120 |
0.0007 |
| 903 |
WOUND |
20 |
0.0007 |
| 904 |
DYSGEUSIA |
52 |
0.0007 |
| 905 |
DIVERTICULITIS |
19 |
0.0007 |
| 906 |
DYSSTASIA |
20 |
0.0007 |
| 907 |
DYSPHONIA |
40 |
0.0007 |
| 908 |
PSYCHOTIC DISORDER |
20 |
0.0007 |
| 909 |
MOBILITY DECREASED |
48 |
0.0007 |
| 910 |
OROPHARYNGEAL PAIN |
61 |
0.0007 |
| 911 |
THROAT IRRITATION |
29 |
0.0006 |
| 912 |
SWOLLEN TONGUE |
20 |
0.0006 |
| 913 |
ABDOMINAL PAIN UPPER |
131 |
0.0006 |
| 914 |
DYSPEPSIA |
62 |
0.0006 |
| 915 |
SPEECH DISORDER |
33 |
0.0006 |
| 916 |
FLUSHING |
64 |
0.0006 |
| 917 |
PARAESTHESIA |
97 |
0.0006 |
| 918 |
ECZEMA |
32 |
0.0006 |
| 919 |
CARDIAC FAILURE CONGESTIVE |
49 |
0.0006 |
| 920 |
ABNORMAL BEHAVIOUR |
24 |
0.0006 |
| 921 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
29 |
0.0006 |
| 922 |
MYALGIA |
102 |
0.0006 |
| 923 |
MEDICATION ERROR |
33 |
0.0006 |
| 924 |
MOVEMENT DISORDER |
19 |
0.0006 |
| 925 |
PERIPHERAL SWELLING |
91 |
0.0006 |
| 926 |
SKIN DISCOLOURATION |
27 |
0.0006 |
| 927 |
VISUAL IMPAIRMENT |
72 |
0.0006 |
| 928 |
OSTEONECROSIS |
19 |
0.0006 |
| 929 |
SWELLING |
54 |
0.0006 |
| 930 |
INJURY |
39 |
0.0006 |
| 931 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
19 |
0.0005 |
| 932 |
EYE PAIN |
30 |
0.0005 |
| 933 |
FLUID RETENTION |
27 |
0.0005 |
| 934 |
BONE PAIN |
30 |
0.0005 |
| 935 |
RHINORRHOEA |
33 |
0.0005 |
| 936 |
HYPERHIDROSIS |
65 |
0.0005 |
| 937 |
INTENTIONAL PRODUCT MISUSE |
44 |
0.0005 |
| 938 |
NECK PAIN |
28 |
0.0005 |
| 939 |
ASTHMA |
56 |
0.0005 |
| 940 |
CEREBROVASCULAR ACCIDENT |
83 |
0.0005 |
| 941 |
GASTROOESOPHAGEAL REFLUX DISEASE |
39 |
0.0005 |
| 942 |
FATIGUE |
376 |
0.0005 |
| 943 |
PAIN |
286 |
0.0005 |
| 944 |
OSTEOPOROSIS |
19 |
0.0005 |
| 945 |
AGGRESSION |
23 |
0.0005 |
| 946 |
MUSCULOSKELETAL PAIN |
24 |
0.0005 |
| 947 |
HEADACHE |
287 |
0.0005 |
| 948 |
CATARACT |
27 |
0.0005 |
| 949 |
BLOOD PRESSURE INCREASED |
69 |
0.0005 |
| 950 |
PAIN IN EXTREMITY |
130 |
0.0004 |
| 951 |
FLATULENCE |
25 |
0.0004 |
| 952 |
BALANCE DISORDER |
38 |
0.0004 |
| 953 |
WEIGHT INCREASED |
98 |
0.0004 |
| 954 |
ALOPECIA |
85 |
0.0004 |
| 955 |
IRRITABILITY |
26 |
0.0004 |
| 956 |
UNDERDOSE |
31 |
0.0004 |
| 957 |
FALL |
141 |
0.0004 |
| 958 |
INFLUENZA LIKE ILLNESS |
34 |
0.0004 |
| 959 |
INSOMNIA |
108 |
0.0004 |
| 960 |
NO ADVERSE EVENT |
73 |
0.0004 |
| 961 |
ILL-DEFINED DISORDER |
24 |
0.0004 |
| 962 |
THERAPY CESSATION |
20 |
0.0004 |
| 963 |
SLEEP DISORDER |
27 |
0.0004 |
| 964 |
ARTHRALGIA |
157 |
0.0004 |
| 965 |
ADVERSE DRUG REACTION |
33 |
0.0004 |
| 966 |
CARDIAC DISORDER |
34 |
0.0004 |
| 967 |
DISCOMFORT |
22 |
0.0004 |
| 968 |
FEELING HOT |
22 |
0.0004 |
| 969 |
CONTUSION |
34 |
0.0004 |
| 970 |
BLOOD GLUCOSE INCREASED |
65 |
0.0003 |
| 971 |
DEPRESSION |
78 |
0.0003 |
| 972 |
VISION BLURRED |
47 |
0.0003 |
| 973 |
DIZZINESS |
170 |
0.0003 |
| 974 |
HOSPITALISATION |
52 |
0.0003 |
| 975 |
GAIT DISTURBANCE |
62 |
0.0003 |
| 976 |
MUSCULOSKELETAL STIFFNESS |
28 |
0.0003 |
| 977 |
ABDOMINAL DISCOMFORT |
53 |
0.0003 |
| 978 |
INTENTIONAL OVERDOSE |
20 |
0.0003 |
| 979 |
DRUG WITHDRAWAL SYNDROME |
27 |
0.0003 |
| 980 |
MUSCLE SPASMS |
55 |
0.0003 |
| 981 |
MYOCARDIAL INFARCTION |
52 |
0.0003 |
| 982 |
ADVERSE EVENT |
27 |
0.0003 |
| 983 |
HOT FLUSH |
22 |
0.0003 |
| 984 |
ANXIETY |
82 |
0.0003 |
| 985 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
49 |
0.0003 |
| 986 |
SUICIDAL IDEATION |
22 |
0.0002 |
| 987 |
EMOTIONAL DISTRESS |
26 |
0.0002 |
| 988 |
JOINT SWELLING |
25 |
0.0002 |
| 989 |
INCORRECT DOSE ADMINISTERED |
45 |
0.0002 |
| 990 |
FEELING ABNORMAL |
44 |
0.0002 |
| 991 |
NASOPHARYNGITIS |
33 |
0.0002 |
| 992 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
21 |
0.0001 |
| 993 |
PRODUCT DOSE OMISSION ISSUE |
30 |
0.0001 |